Leading artificial intelligence company to advance WEF’s initiative to transform the world of healthcare using technology

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it is joining the World Economic Forum as part of the Innovator Communities. Named a Unicorn sub-community member, Viz.ai will be offering unique insights and solutions to global healthcare-related issues and how to harness the power of artificial intelligence for common good.

“We are honored to join the world’s top companies to positively shape our shared future, as a member of the World Economic Forum’s Innovator Communities,” said Chris Mansi, MD, CEO at Viz.ai. “It is critical that businesses, governments, and other key stakeholders collaborate to create more resilient, efficient, and equitable healthcare systems and being part of the Forum facilitates our aim to deliver the best possible patient care across nations.”

The Innovator Communities is an invitation-only group of the world’s most promising start-ups and scale-ups at the forefront of technological and business model innovation. Comprised of three sub-communities, the Technology Pioneers, Global Innovators, and Unicorns, the Innovator Communities accompany start-ups along their growth journey. The World Economic Forum provides a platform for organizations like Viz.ai to engage with public- and private-sector leaders and to contribute new solutions to overcome current crises and build future resiliency. Specifically, the Unicorn Community was newly launched by the Forum to unite leading private start-ups valued at more than one billion USD.

About Viz.ai

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 220 million lives across 1,400+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230627741043/en/